search
Back to results

Craniosacral Therapy as a Self-help Strategy for Patients With Chronic Non-specific Back Pain (CRANIO4ME)

Primary Purpose

Low Back Pain, Mechanical, Complementary Therapies, Progressive Muscle Relaxation

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Craniosacral Therapy (CST) self-help techniques
Progressive Muscle Relaxation (PMR)
Sponsored by
Universität Duisburg-Essen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain, Mechanical focused on measuring Craniosacral Therapy, Low Back Pain, Chronic, Randomized Controlled Trial, Self-help

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic non-specific / functional lower back pain for at least 3 months
  • Functional impairment: 9-20 points on the RMDQ
  • Willingness to participate in the group program and practice at home

Exclusion Criteria:

  • Specific back pain due to:
  • Severe congenital or acute degenerative diseases
  • Severe inflammatory musculoskeletal or rheumatic diseases
  • Neurological diseases
  • Status after actue trauma/whiplash
  • Status after neoplasms in the area of the spinal column
  • Acute severe comorbid mental illness or other acute severe comorbid somatic illness
  • Pregnancy
  • Current pension application
  • Regular use of corticosteroids, opiates, muscle relaxants, or antidepressants
  • Simultaneous participation in other clinical trials

Sites / Locations

  • Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-EssenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Craniosacral self-help techniques (CST)

Progressive muscle relaxation (PMR)

Arm Description

The experimental group consists of 24 teaching units (TUs) à 45 minutes over 12 weeks. The course starts with an introductory day (8 TUs), followed by 6 practice evenings every two weeks (2 TUs each) and a final afternoon (4 TUs). The patients will also receive a script with theoretical CST basics and descriptions of the techniques, which should facilitate the correct practice at home.

The active control group consists of 24 teaching units (TUs) à 45 minutes over 12 weeks. Every week patients will meet for 2 TUs. The patients will also receive a script with theoretical basics and descriptions of the PMR techniques, hich should facilitate the correct practice at home.

Outcomes

Primary Outcome Measures

Functional Impairment
Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.

Secondary Outcome Measures

Functional Impairment
Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.
Functional Impairment
Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.
Pain Intensity
Numeric rating scale (NRS): Self-report scale from 0-10 points with 0=no pain and 10=worst pain.
Pain Intensity
Numeric rating scale (NRS): Self-report scale from 0-10 points with 0=no pain and 10=worst pain.
Pain Intensity
Numeric rating scale (NRS): Self-report scale from 0-10 points with 0=no pain and 10=worst pain.
Health-related Quality of Life
Short Form Health Survey (SF-12): Self-report scale with two subscales (physical and mental qualityy of life). Higher scores indicate better health-related quality of life.
Health-related Quality of Life
Short Form Health Survey (SF-12): Self-report scale with two subscales (physical and mental qualityy of life). Higher scores indicate better health-related quality of life.
Health-related Quality of Life
Short Form Health Survey (SF-12): Self-report scale with two subscales (physical and mental qualityy of life). Higher scores indicate better health-related quality of life.
Severity of Depressive Symptoms
Center for Epidemiologic Studies Depression Scale (CES-D): 10-item self-report short form of the CES-D. Higher scores indicate higher severity of depressive symptoms.
Severity of Depressive Symptoms
Center for Epidemiologic Studies Depression Scale (CES-D): 10-item self-report short form of the CES-D. Higher scores indicate higher severity of depressive symptoms.
Severity of Depressive Symptoms
Center for Epidemiologic Studies Depression Scale (CES-D): 10-item self-report short form of the CES-D. Higher scores indicate higher severity of depressive symptoms.
Severity of Anxious Symptoms
Patient-Reported Outcomes Measurement Information System (PROMIS): 7-item self-report anxiety subscale. Higher scores indicate higher severity of anxious symptoms.
Severity of Anxious Symptoms
Patient-Reported Outcomes Measurement Information System (PROMIS): 7-item self-report anxiety subscale. Higher scores indicate higher severity of anxious symptoms.
Severity of Anxious Symptoms
Patient-Reported Outcomes Measurement Information System (PROMIS): 7-item self-report anxiety subscale. Higher scores indicate higher severity of anxious symptoms.
Global Improvement
Patient Global Impression of Improvement Scale (PGI-I): 7-point self-report scale from 1=very much improved to 7=very much worse.
Global Improvement
Patient Global Impression of Improvement Scale (PGI-I): 7-point self-report scale from 1=very much improved to 7=very much worse.
Global Improvement
Patient Global Impression of Improvement Scale (PGI-I): 7-point self-report scale from 1=very much improved to 7=very much worse.
Number of Patients with Adverse Events
Number of Patients with Adverse Events
Total Number (and Type) of Adverse Events
Total Number (and Type) of Adverse Events

Full Information

First Posted
December 9, 2019
Last Updated
August 1, 2023
Sponsor
Universität Duisburg-Essen
search

1. Study Identification

Unique Protocol Identification Number
NCT04199091
Brief Title
Craniosacral Therapy as a Self-help Strategy for Patients With Chronic Non-specific Back Pain
Acronym
CRANIO4ME
Official Title
Craniosacral Therapy Versus Progressive Muscle Relaxation as Self-help Strategies for Patients With Chronic Non-specific Back Pain: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2023 (Actual)
Primary Completion Date
January 2025 (Anticipated)
Study Completion Date
October 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universität Duisburg-Essen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Craniosacral Therapy (CST) is a non-manipulative, very gentle manual treatment method. Although the mechanisms of action have not yet been investigated sufficiently, initial clinical trials support CST efficacy/effectiveness in chronic pain disorders such as back pain, neck pain, and fibromyalgia. In clinical practice, therapists also report pain alleviating effects of CST self-help techniques, offered to patients within a group concept. Yet, the effectiveness of teaching CST self-help techniques to medical laypersons has not yet been scientifically investigated. Therefore, this study aims at collecting quantifiable data on the effectiveness and safety of a CST self-help group concept, developed for patients with chronic non-specific low back pain. The intervention group will receive 24 lessons of education and practice in CST self-help techniques over 12 weeks, while the control group will receive the same amount of self-help (education and practice) in progressive muscle relaxation. Six and 12 months after randomization, longer-term effects will be investigated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain, Mechanical, Complementary Therapies, Progressive Muscle Relaxation
Keywords
Craniosacral Therapy, Low Back Pain, Chronic, Randomized Controlled Trial, Self-help

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
The investigator who will perform the group assignment will have no contact to the study participants. The outcome assessors will be blinded to group allocation. Patients will partly be blinded to the group intervention: The will be told that they will receive one of two self-help therapies - one that focus on the relaxation of fasciae and the other that focus on the relaxation of muscles. The statistician who will perform the analyses will kept blind to the group intervention by renaming groups with numbers.
Allocation
Randomized
Enrollment
76 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Craniosacral self-help techniques (CST)
Arm Type
Experimental
Arm Description
The experimental group consists of 24 teaching units (TUs) à 45 minutes over 12 weeks. The course starts with an introductory day (8 TUs), followed by 6 practice evenings every two weeks (2 TUs each) and a final afternoon (4 TUs). The patients will also receive a script with theoretical CST basics and descriptions of the techniques, which should facilitate the correct practice at home.
Arm Title
Progressive muscle relaxation (PMR)
Arm Type
Active Comparator
Arm Description
The active control group consists of 24 teaching units (TUs) à 45 minutes over 12 weeks. Every week patients will meet for 2 TUs. The patients will also receive a script with theoretical basics and descriptions of the PMR techniques, hich should facilitate the correct practice at home.
Intervention Type
Procedure
Intervention Name(s)
Craniosacral Therapy (CST) self-help techniques
Intervention Description
Manual self-help techniques based on Craniosacral Therapy (group setting).
Intervention Type
Procedure
Intervention Name(s)
Progressive Muscle Relaxation (PMR)
Intervention Description
Progressive muscle relaxation according to Jacobsen (group setting).
Primary Outcome Measure Information:
Title
Functional Impairment
Description
Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.
Time Frame
Week 12
Secondary Outcome Measure Information:
Title
Functional Impairment
Description
Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.
Time Frame
Week 26
Title
Functional Impairment
Description
Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.
Time Frame
Week 52
Title
Pain Intensity
Description
Numeric rating scale (NRS): Self-report scale from 0-10 points with 0=no pain and 10=worst pain.
Time Frame
Week 12
Title
Pain Intensity
Description
Numeric rating scale (NRS): Self-report scale from 0-10 points with 0=no pain and 10=worst pain.
Time Frame
Week 26
Title
Pain Intensity
Description
Numeric rating scale (NRS): Self-report scale from 0-10 points with 0=no pain and 10=worst pain.
Time Frame
Week 52
Title
Health-related Quality of Life
Description
Short Form Health Survey (SF-12): Self-report scale with two subscales (physical and mental qualityy of life). Higher scores indicate better health-related quality of life.
Time Frame
Week 12
Title
Health-related Quality of Life
Description
Short Form Health Survey (SF-12): Self-report scale with two subscales (physical and mental qualityy of life). Higher scores indicate better health-related quality of life.
Time Frame
Week 26
Title
Health-related Quality of Life
Description
Short Form Health Survey (SF-12): Self-report scale with two subscales (physical and mental qualityy of life). Higher scores indicate better health-related quality of life.
Time Frame
Week 52
Title
Severity of Depressive Symptoms
Description
Center for Epidemiologic Studies Depression Scale (CES-D): 10-item self-report short form of the CES-D. Higher scores indicate higher severity of depressive symptoms.
Time Frame
Week 12
Title
Severity of Depressive Symptoms
Description
Center for Epidemiologic Studies Depression Scale (CES-D): 10-item self-report short form of the CES-D. Higher scores indicate higher severity of depressive symptoms.
Time Frame
Week 26
Title
Severity of Depressive Symptoms
Description
Center for Epidemiologic Studies Depression Scale (CES-D): 10-item self-report short form of the CES-D. Higher scores indicate higher severity of depressive symptoms.
Time Frame
Week 52
Title
Severity of Anxious Symptoms
Description
Patient-Reported Outcomes Measurement Information System (PROMIS): 7-item self-report anxiety subscale. Higher scores indicate higher severity of anxious symptoms.
Time Frame
Week 12
Title
Severity of Anxious Symptoms
Description
Patient-Reported Outcomes Measurement Information System (PROMIS): 7-item self-report anxiety subscale. Higher scores indicate higher severity of anxious symptoms.
Time Frame
Week 26
Title
Severity of Anxious Symptoms
Description
Patient-Reported Outcomes Measurement Information System (PROMIS): 7-item self-report anxiety subscale. Higher scores indicate higher severity of anxious symptoms.
Time Frame
Week 52
Title
Global Improvement
Description
Patient Global Impression of Improvement Scale (PGI-I): 7-point self-report scale from 1=very much improved to 7=very much worse.
Time Frame
Week 12
Title
Global Improvement
Description
Patient Global Impression of Improvement Scale (PGI-I): 7-point self-report scale from 1=very much improved to 7=very much worse.
Time Frame
Week 26
Title
Global Improvement
Description
Patient Global Impression of Improvement Scale (PGI-I): 7-point self-report scale from 1=very much improved to 7=very much worse.
Time Frame
Week 52
Title
Number of Patients with Adverse Events
Description
Number of Patients with Adverse Events
Time Frame
Week 12
Title
Total Number (and Type) of Adverse Events
Description
Total Number (and Type) of Adverse Events
Time Frame
Week 12
Other Pre-specified Outcome Measures:
Title
Body Awareness
Description
Body Responsiveness Questionnaire (BRQ): 7-iten self-report scale with 3 subscales (Importance of Interoceptive Awareness, Perceived Connection, Suppression of Bodily Sensations). Higher scores indicate higher body awareness on the two subscales Importance of Interoceptive Awareness and Perceived Connection, while higher scores indicate lower body awareness on the subscale Suppression of Bodily Sensations.
Time Frame
Week 12
Title
Body Awareness
Description
Body Responsiveness Questionnaire (BRQ): 7-iten self-report scale with 3 subscales (Importance of Interoceptive Awareness, Perceived Connection, Suppression of Bodily Sensations). Higher scores indicate higher body awareness on the two subscales Importance of Interoceptive Awareness and Perceived Connection, while higher scores indicate lower body awareness on the subscale Suppression of Bodily Sensations.
Time Frame
Week 26
Title
Body Awareness
Description
Body Responsiveness Questionnaire (BRQ): 7-iten self-report scale with 3 subscales (Importance of Interoceptive Awareness, Perceived Connection, Suppression of Bodily Sensations). Higher scores indicate higher body awareness on the two subscales Importance of Interoceptive Awareness and Perceived Connection, while higher scores indicate lower body awareness on the subscale Suppression of Bodily Sensations.
Time Frame
Week 52
Title
Fear-related Avoidance Beliefs
Description
Fear Avoidance Belief Questionnaire (FABQ): 16-item self-report scale with two subscales (fear-avoidance beliefs about physical activity and fear-avoidance beliefs about work). Higher scores indicate higher fear-avoidance beliefs.
Time Frame
Week 12
Title
Fear-related Avoidance Beliefs
Description
Fear Avoidance Belief Questionnaire (FABQ): 16-item self-report scale with two subscales (fear-avoidance beliefs about physical activity and fear-avoidance beliefs about work). Higher scores indicate higher fear-avoidance beliefs.
Time Frame
Week 26
Title
Fear-related Avoidance Beliefs
Description
Fear Avoidance Belief Questionnaire (FABQ): 16-item self-report scale with two subscales (fear-avoidance beliefs about physical activity and fear-avoidance beliefs about work). Higher scores indicate higher fear-avoidance beliefs.
Time Frame
Week 52
Title
Pain Acceptance
Description
Chronic Pain Acceptance Questionnaire (CPAQ): 20-item self-report scale one sumscale and two subscales (activity engagement and pain willingness). Higher schroes indicate higher pain acceptance.
Time Frame
Week 12
Title
Pain Acceptance
Description
Chronic Pain Acceptance Questionnaire (CPAQ): 20-item self-report scale one sumscale and two subscales (activity engagement and pain willingness). Higher schroes indicate higher pain acceptance.
Time Frame
Week 26
Title
Pain Acceptance
Description
Chronic Pain Acceptance Questionnaire (CPAQ): 20-item self-report scale one sumscale and two subscales (activity engagement and pain willingness). Higher schroes indicate higher pain acceptance.
Time Frame
Week 52
Title
Use of Pain Medication
Description
The amount of pain medication during the active study period will be assessed by Defined Daily Doses (DDD) via a diary.
Time Frame
Week 1-12
Title
Freuqnecy of Homework
Description
The total time of performed homework (CST or PMR) during the active study period will be assessed via a diary.
Time Frame
Week 1-12
Title
Treatment Expectations
Description
Treatment Credibility Scale (TCS): 1-item self-report numeric rating subscale of the TCS ("Are you confident this treatment will alleviate the pain you feel?") from 0=totally disagree to 10=totally agree. Higher scores indicate higher treamtent expectations.
Time Frame
Week 1
Title
Treamtent Credibility
Description
Treatment Credibility Scale (TCS): 3-item self-report numeric rating subscale of the TCS from 0=totally disagree to 10=totally agree. Higher scores indicate higher treamtent credibility.
Time Frame
Week 12
Title
Therapist-Patient-Relationship
Description
Helping Alliance Questionnaire (HAQ): 11-item self-report scale with two subscales (quality of the therapeutic relation and satisfaction with the treatment). Higher scores indicate a higher quality of the therapeutic relation / a higher satisfaction.
Time Frame
Week 12
Title
Interview
Description
Semi-structured interview based on body image & pain drawings (at week 1 and 12)
Time Frame
Week 12
Title
Craniosacral-specific Quality of Life
Description
Warwick Holistic Health Questionnaire (WHHQ): 25-item scale ranging from 0 to 100 points. Higher scores indicate higher craniosacral-specific quality of life.
Time Frame
Week 12
Title
Craniosacral-specific Quality of Life
Description
Warwick Holistic Health Questionnaire (WHHQ): 25-item scale ranging from 0 to 100 points. Higher scores indicate higher craniosacral-specific quality of life.
Time Frame
Week 26
Title
Craniosacral-specific Quality of Life
Description
Warwick Holistic Health Questionnaire (WHHQ): 25-item scale ranging from 0 to 100 points. Higher scores indicate higher craniosacral-specific quality of life.
Time Frame
Week 52

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic non-specific / functional lower back pain for at least 3 months Functional impairment: minimal 11 and maximal 41 points on the ODI Willingness to participate in the group program and practice at home Exclusion Criteria: Specific back pain due to: Severe congenital or acute degenerative diseases Severe inflammatory musculoskeletal or rheumatic diseases Neurological diseases Status after actue trauma/whiplash Status after neoplasms in the area of the spinal column Acute severe comorbid mental illness or other acute severe comorbid somatic illness Pregnancy Current pension application Regular use of corticosteroids, opiates, muscle relaxants, or antidepressants Simultaneous participation in other clinical trials
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Heidemarie Haller, PhD
Phone
+4920172377384
Email
heidemarie.haller@uk-essen.de
First Name & Middle Initial & Last Name or Official Title & Degree
Holger Cramer, PhD
Email
holger.cramer@med.uni-tuebingen.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gustav Dobos, Prof. MD
Organizational Affiliation
Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen
Official's Role
Study Director
Facility Information:
Facility Name
Center for Integrative Medicine and Planetary Health, University Hospital Essen, University of Duisburg-Essen
City
Essen
State/Province
NRW
ZIP/Postal Code
45130
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Heidemarie Haller, PhD
Phone
+4920172377384
Email
heidemarie.haller@uk-essen.de
First Name & Middle Initial & Last Name & Degree
Theresa Dührung
Email
theresa.duering@uk-essen.de

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Craniosacral Therapy as a Self-help Strategy for Patients With Chronic Non-specific Back Pain

We'll reach out to this number within 24 hrs